[2-Amino-2-(3-bromo-phenyl)-ethyl]-carbamic acid tert-butyl ester(1086392-07-5)
- Name: [2-Amino-2-(3-bromo-phenyl)-ethyl]-carbamic acid tert-butyl ester
- Synonyms:1086392-07-5;[2-Amino-2-(3-bromo-phenyl)-ethyl]-carbamic acid tert-butyl ester;tert-Butyl (2-amino-2-(3-bromophenyl)ethyl)carbamate;(2-amino-2-(3-bromophenyl)ethyl)carbamic acid tert-butyl ester;[2-amino-2-(3-bromophenyl)ethyl]carbamic acid tert-butyl ester;DTXSID401143356;SB30546;CS-0440573;EN300-1878033;2-amino-2-(3-bromophenyl)ethylcarbamic acid tert-butyl ester;TERT-BUTYL N-[2-AMINO-2-(3-BROMOPHENYL)ETHYL]CARBAMATE;Carbamic acid, N-[2-amino-2-(3-bromophenyl)ethyl]-, 1,1-dimethylethyl ester
- Molecular Formula:C13H19BrN2O2
- Molecular Weight:315.21
- CAS Registry Number:1086392-07-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1086392-07-5 [2-Amino-2-(3-bromo-phenyl)-ethyl]-carbamic acid tert-butyl ester;1086392-07-5
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal ChemistryBiomedicinePharmaceutical intermediatesChemistry experimentBiological experimentsChemical reagentFor R&D use only.
Min. Order:10Metric Ton
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)]
Other Product
- 1613220-15-7/Niraparib tosylate monohydrate
- 1323966-46-6/2-Fluoro-5-methyl-4-(trifluoromethyl)phenylacetic acid
- 1539440-00-0/2,3-Dihydrofuro[3,2-c]pyridin-4-amine
- 2311-65-1/(8R,9S,10R,13S,14S,17R)-10,13-dimethylspiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]-3,3'-dione
- 939758-33-5/2-(Chloromethyl)-5-(trifluoromethyl)benzenamine
- 1160251-29-5/4-[(3,4-Dichlorobenzyl)oxy]-3-ethoxybenzoyl chloride
- 1160254-49-8/2-(4-Ethoxyphenyl)-8-methylquinoline-4-carbonyl chloride
- 1217669-56-1/(2R,3R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-hydroxy-3-(p-tolyl)propanoic acid
- 40323-42-0/2,5,10-Tributylhexahydro-1h,3ch-3b,8-ethenodipyrrolo[3,4-b:3',4'-e]pyrrolo[3',4':3,4]pyrrolo[2,1-i]indole-1,3,4,6,9,11(2h,5h,6ah,8h,10h)-hexone
- 864058-75-3/5-[(4-Bromothiophen-2-yl)sulfanyl]-1-methyl-1,3-dihydro-2H-indol-2-one
- 910251-35-3/Potassium (acetoxymethyl)trifluoroborate
- 910381-48-5/6-Quinolineethanamine
- 1422649-48-6/Pentasodium 4-amino-3-[(2,4-disulfonatophenyl)diazenyl]-5-hydroxy-6-[(4-nitro-2-sulfonatophenyl)diazenyl]naphthalene-1,7-disulfonate
- 55145-90-9/(4-Aminophenyl)-phenyliodanium;hydrobromide
- 6697-23-0/(4Ar,4bs,6as,6bs,9ar,10as,10br,12s)-6b-acetyl-4a,6a,8,8,12-pentamethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2h-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
- 7229-24-5/7229-24-5 (Name error)
- 900019-69-4/2-(3-Fluoro-4-morpholin-4-ylbenzoyl)-3-(3-methoxyphenyl)prop-2-enenitrile
- 1322200-79-2/2-(3-Methoxyphenyl)propan-2-amine hydrochloride
- 1340120-25-3/1-(2,4-Difluorophenyl)cyclopentan-1-amine
- 1086392-07-5/[2-Amino-2-(3-bromo-phenyl)-ethyl]-carbamic acid tert-butyl ester
- 4960-64-9/2-[4-(2-Aminoethyl)phenoxy]ethanol
- 5432-80-4/Sulfuric acid--N'',N'''-[azanediyldi(propane-3,1-diyl)]diguanidine (1/1)
- 1965309-89-0/4,4-Dimethyl-1,2,3,4-tetrahydro-quinoline-6-carbonitrile hydrochloride
- 2070009-29-7/Naltrexone D4
- 1220035-90-4/4-{[2-Chloro-4-(tert-pentyl)phenoxy]-methyl}piperidine hydrochloride
- 1260779-60-9/6-Bromo-3-methyl-1,8-naphthyridin-2(1H)-one
- 1000534-18-8/2-(3-Fluoro-5-methylphenyl)ethan-1-ol
- 1187-01-5/Degranol
- 850141-19-4/2-epi-Darunavir
- 1296149-13-7/Glucosamine sulfate sodium chloride [WHO-DD]